Diabetes induces changes in melatonin concentrations in peripheral tissues of rat

Neuroendocrinology Letters

Volumn 28, Issue 2, 2007, Pages 159-165

  Stebelová, Katarína ^a   Herichová, Iveta ^a   Zeman, Michal ^a  

^a Physics and Informatics   (Slovakia)

Author keywords

Circadian; Corticosterone; Diabetes; Gut; Kidney; Melatonin; Pancreas

Indexed keywords

CORTICOSTERONE; GLUCOSE; MELATONIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CIRCADIAN RHYTHM; COLON; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; DUODENUM; KIDNEY; MALE; NIGHT; NONHUMAN; PANCREAS; PINEAL BODY; RADIOIMMUNOASSAY; RAT; SPLEEN; STREPTOZOCIN DIABETES; TIME;

EID: 34248581860     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Aksoy N, Vural H, Sabuncu T, Aksoy S. Effects of melatonin on oxidative-antioxidative status of tissues in streptozotocin-induced diabetic rats, Cell Biochem Funct 2003; 21: 121-125.
2. Andersson AK, Sandler S. Melatonin protects against streptozotocin, but not interieukin-1beta-induced damage of rodent pancreatic beta-cells. J Pineal Res 2001; 30: 157-165.
3. Bonilla E, Valero N, Chacin-Bonilla L, Pons H, Larreal Y, Medina-Leendertz S, et al. Melatonin increases interleukin-1 beta and decreases tumor necrosis factor alpha in the brain of mice infected with the Venezuelan equine encephalomyelitis virus. Neurochem Res 2003; 28: 681-686.
4. Bubenik GA. Localization, physiological significance and possible clinical implication of gastrointestinal melatonin. Biol Signals Recept 2001; 10:350-366.
5. Bubenik GA, Niles LP, Pang SF, Pentney PJ. Diurnal variation and binding characteristics of melatonin in the mouse brain and gastrointestinal tissues. Comp Biochem Physiol C 1993; 104: 221-224.
6. Buijs RM, van Eden CG, Goncharuk VD, Kalsbeek A. The biological clock tunes the organs of the body: timing by hormones and the autonomic nervous system. J Endocrinol 2003; 177: 17-26.
7. Cam M, Yavuz O, Guven A, Ercan F, Bukan N, Ustundag N. Protective effects of chronic melatonin treatment against renal injury in streptozotocin-induced diabetic rats. J Pineal Res 2003; 35: 212-220.
8. Carrillo-Vico A, Guerrero JM, Lardone PJ, Reiter RJ. A review of the multiple actions of melatonin on the immune system. Endocrine 2005; 27: 189-200.
9. Diaz B, Blazquez E. Effect of pinealectomy on plasma glucose, insulin and glucagon levels in the rat. Horm Metab Res 1986; 18: 225-229.
10. Fraser S, Cowen P, Franklin M, Franey C, Arendt J. Direct radioimmunoassay for melatonin in plasma. Clin Chem 1983; 29: 396-401.
11. Herichova I, Zeman M. Rhythmic changes melatonin in the circulation and tissues of broiler chickens. Vet Med 1999; 44: 263-267.
12. Herichova I, Zeman M, Jurani M, Lamosova D. Daily rhythms of melatonin and selected biochemical parameters in plasma of Japanese quail. Avian Poultry Biol Rev 2004; 15: 205-210.
13. Herichova I, Zeman M, Stebelova K, Ravingerova T. Effect of streptozotocin-induced diabetes on daily expression of per2 and dbp in the heart and liver and melatonin rhythm in the pineal gland of Wistar rat. Mol Cell Biochem 2005; 270: 223-229.
14. Champney TH, Brainard GC, Richadson BA, Reiter RJ. Experimentally-induced diabetes reduces nocturnal pineal melatonin. Comp Biochem Physiol A 1983; 76:199-201.
15. Champney TH, Holtorf AP, Craft CM, Reiter RJ. Hormonal modulation of pineal melatonin synthesis in rats and Syrian hamsters: effects of streptozotocin-induced diabetes and insulin injections. Comp Biochem Physiol A 1986; 83: 391-395.
16. Chan O, Inouye K, Vranic M, Matthews SG. Hyperactivation of the hypothalamo-pituitary-adrenocortical axis in streptozotocin-diabetes is associated with reduced stress responsiveness and decreased pituitary and adrenal sensitivity. Endocrinology 2002; 143: 1761-1768.
17. Jaworek J, Konturek SJ, Tomaszewska R, Leja-Szpak A, Bonior J, Nawrot K, et al. The circadian rhythm of melatonin modulates the severity of caerulein-induced pancreatitis in the rat. J Pineal Res 2004; 37: 161-170.
18. Karasek M, Szuflet A, Chrzanowski W, Zylinska K, Swietoslawski J. Circadian serum melatonin profiles in patients suffering from chronic renal failure. Neuro Endocrinol Lett 2002; 23 Suppl 1: 97-102.
19. Klemfuss H, Clopton PL. Seeking tau: a comparison of six methods. J Interdisciplinary Cycle Res 1993; 24: 1-16.
20. Larkins RG, Dunlop ME. The link between hyperglycaemia and diabetic nephropathy. Diabetologia 1992; 35: 499-504.
21. Lynch HJ, Eng JP, Wurtman RJ. Control of pineal indole biosynthesis by changes in sympathetic tone caused by factors other than environmental lighting. Proc Natl Acad Sci USA 1973; 70: 1704-1707.
22. Mellado C, Rodriguez V, de Diego JG, Alvarez E, Blazquez E. Effect of pinealectomy and of diabetes on liver insulin and glucagon receptor concentrations in the rat. J Pineal Res 1989; 6: 295-306.
23. Messner M, Hardeland R, Rodenbeck A, Huether G. Tissue retention and subcellular distribution of continuously infused melatonin in rats under near physiological conditions. J Pineal Res 1998; 25: 251-259.
24. Muhlbauer E, Wolgast S, Finckh U, Peschke D, Peschke E. Indication of circadian oscillations in the rat pancreas. FEBS Lett 2004; 564: 91-96.
25. Nagamatsu T, Oka T, Nagao T, Suzuki Y. Effects of KD3-671, an angiotensin II type 1 receptor antagonist, on anti-thy-1 nephritis in rats. Biol Pharm Bull 2003; 26: 808-812.
26. Namboodiri MA, Favilla JT, Klein DC. Pineal N-acetyltransferase is inactivated by disulfide-containing peptides: insulin is the most potent. Science 1981; 213: 571-573.
27. Nelson W, Tong YL, Lee JK, Halberg F. Methods for cosinor-rhythmometry. Chronobiologia 1979; 6: 305-323.
28. Nishida S, Sato R, Murai I, Nakagawa S. Effect of pinealectomy on plasma levels of insulin and leptin and on hepatic lipids in type 2 diabetic rats. J Pineal Res 2003; 35: 251-256.
29. Nishida S, Segawa T, Murai I, Nakagawa S. Long-term melatonin administration reduces hyperinsulinemia and improves the altered fatty-acid compositions in type 2 diabetic rats via the restoration of Delta-5 desaturase activity. J Pineal Res 2002; 32: 26-33.
30. Oster MH, Castonguay TW, Keen CL, Stern JS. Circadian rhythm of corticosterone in diabetic rats. Life Sci 1988; 43: 1643-1645.
31. Peschke E, Bach AG, Muhlbauer E. Parallel signaling pathways of melatonin in the pancreatic beta-cell. J Pineal Res 2006; 40: 184-191.
32. Peschke E, Frese T, Chankiewitz E, Peschke D, Preiss U, Schneyer U, et al. Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status. J Pineal Res 2006; 40: 135-143.
33. Poirel VJ, Cailotto C, Streicher D, Pevet P, Masson-Pevet M, Gauer F. MT1 melatonin receptor mRNA tissular localization by PCR amplification. Neuro Endocrinol Lett 2003; 24: 33-38.
34. Radziuk J, Pye S. Endogenous glucose production in type 2 diabetes: basal and postprandial. Role of diurnal rhythms. J Investig Med 2004; 52: 379-388.
35. Rasmussen DD, Boldt BM, Wilkinson CW, Yellon SM, Matsumoto AM. Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels. Endocrinology 1999; 140: 1009-1012. Erratum in: Endocrinology 2002; 143: 1269.
36. Reiter RJ. Potential biological consequences of excessive light exposure: melatonin suppression, DNA damage, cancer and neurodegenerative diseases. Neuro Endocrinol Lett 2002; 23: 9-13.
37. Reiter RJ, Tan DX, Mayo JC, Sainz RM, Leon J, Bandyopadhyay D. Neurally-mediated and neurally-independent beneficial actions of melatonin in the gastrointestinal tract. J Physiol Pharmacol 2003; 54 Suppl 4: 113-125.
38. Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature 2002; 418: 935-941.
39. Reyes-Toso CF, Linares LM, Ricci CR, Aran M, Pinto JE, Rodriguez RR, et al. Effect of melatonin on vascular reactivity in pancreatectomized rats. Life Sci 2004; 74: 3085-3092.
40. Reyes-Toso CF, Roson MI, Albornoz LE, Damiano PF, Linares LM, Cardinali DP. Vascular reactivity in diabetic rats: effect of melatonin. J Pineal Res 2002; 33: 81-86.
41. Sallinen P, Saarela S, Ilves M, Vakkuri O, Leppaluoto J. The expression of MT1 and MT2 melatonin receptor mRNA in several rat tissues. Life Sci 2005; 76: 1123-1134.
42. Schibler U, Ripperger J, Brown SA. Peripheral circadian oscillators in mammals: time and food. J Biol Rhythms 2003; 18: 250-260.
43. Stebelova K, Zeman M, Cornelissen G, Bubenik G, Jozsa R, Hardeland R, et al. Chronomics reveal and quantify circadian rhythmic melatonin in duodenum of rats. Biomed Pharmacother 2005; 59 Suppl 1: 209-212.
44. Touitou Y, Portaluppi F, Smolensky MH, Rensing L. Ethical principles and standards for the conduct of human and animal biological rhythm research. Chronobiol Int 2004; 21: 161-170.
45. Velasco S, Huertla I, Marin B. Plasma corticosterone, motor activity and metabolic circadian patterns in streptozotocin-induced diabetic rats. Chronobiol Int 1988; 5: 127-135.
46. Wolden-Hanson T, Mitton DR, McCants RL, Yellon SM, Wilkinson CW, Matsumoto AM, et al. Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. Endocrinology 2000; 141: 487-497.
47. Young ME, Razeghi P, Taegtmeyer H. Clock genes in the heart: characterization and attenuation with hypertrophy. Circ Res 2001; 88: 1142-1150.
48. Zeman M, Nosalova V, Bobek P, Zakalova M. Changes of endogenous melatonin and protective effect of diet containing pleuran and extract of black elder in colonic inflammation in rats. Biologia 2001; 56: 691-697.